𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Low dose of homoharringtonine and cytarabine combined with granulocyte colony-stimulating factor priming on the outcome of relapsed or refractory acute myeloid leukemia

✍ Scribed by Liu-Fang Gu; Wang-Gang Zhang; Fang-Xia Wang; Xing-Mei Cao; Yin-Xia Chen; Ai-Li He; Jie Liu; Xiao-Rong Ma

Publisher
Springer-Verlag
Year
2010
Tongue
English
Weight
230 KB
Volume
137
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Combination chemotherapy with low-dose c
Combination chemotherapy with low-dose cytarabine, homoharringtonine, and granulocyte colony-stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia
✍ Wang-Gang Zhang; Fang-Xia Wang; Yin-Xia Chen; Xin-Mei Cao; Ai-Li He; Jie Liu; Xi πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 98 KB πŸ‘ 2 views

## Abstract As sensitization of leukemic cells with granulocyte colony‐stimulating factor (G‐csf) can enhance the cytotoxicity of chemotherapy in acute myeloid leukemia (AML), a pilot study was conducted in order to evaluate the effect of G‐csf priming combined with low‐dose chemotherapy in patient

Continuous drip infusion of low dose cyt
Continuous drip infusion of low dose cytarabine and etoposide with granulocyte colony-stimulating factor for elderly patients with acute myeloid leukaemia ineligible for intensive chemotherapy
✍ Nobuhiro Kanemura; Hisashi Tsurumi; Senji Kasahara; Takeshi Hara; Toshiki Yamada πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 106 KB

## Abstract ## Backgrounds and objectives The optimal strategy for the management of elderly patients with acute myeloid leukaemia (AML) is still controversial. We previously reported the effectiveness of low dose cytarabine (Ara‐C) and etoposide (VP‐16) (AV therapy) for those elderly AML patients